Abstract

Further Clarification of HIPAA Regulations

Author(s): Bishop Susan K, Winckler Susan, King LD

Issue: May/Jun 2003 - Diabetes and Wound Care

Page(s): 195

Download in electronic PDF format for $75

Abstract

This brief article poses and answers three questions: Who has to comply with the Health Insurance Portability and Accountability Act (HIPAA) of 1996? If I am not a covered entity, what should I do? And where can I find additional information on HIPAA?

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2003 Pg. 195	Further Clarification of HIPAA Regulations Author(s): Bishop Susan K, Winckler Susan, King LD
Jan/Feb 2008 Pg. 63	Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 277-279	HIPAA Privacy and Security for Providers: The Basics Author(s): Kuruc Jullian H
May/Jun 2013 Pg. 182-190	Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Author(s): Mixon Bill, Nain John
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 356	PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 209-211	Survey of State Veterinary Compounding Laws and Regulations Author(s): Goodrum Jennifer
Nov/Dec 2003 Pg. 495	PostScription: Changing Pharmacy Regulations Could Affect US Compounders Author(s): Downing Pat, Roberson Kim
May/Jun 2013 Pg. 210-219	Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 514-523	Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Author(s): Baker Kenneth R
Sep/Oct 2008 Pg. 420-424	Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Author(s): Baker Kenneth R
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Sep/Oct 2014 Pg. 438-439	PostScription: The Future of Veterinary Compounding Author(s): Jordan Dinah G
May/Jun 2021 Pg. 190-195	Insurance Considerations for the Pharmacy Professional Author(s): Jones Kirsten
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake